Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NVS - Alexion up 8% on Soliris performance bump from Novartis' LNP023


NVS - Alexion up 8% on Soliris performance bump from Novartis' LNP023

  • Alexion Pharmaceuticals (ALXN +8.4%) is up on more than 50% higher volume in reaction to Novartis' (NVS -0.1%) announcement of positive results from an open-label, Phase 2 clinical trial evaluating investigational oral treatment LNP023 in patients with paroxysmal nocturnal hemoglobinuria (PNH).
  • More news on: Alexion Pharmaceuticals, Inc., Novartis AG, Healthcare stocks news, Stocks on the move,
  • Read more ...
Stock Information

Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com

Menu

NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...